title: Design of a covalently bonded glycosphingolipid microarray.
abstract: Glycosphingolipids (GSLs) are well known ubiquitous constituents of all eukaryotic cell membranes, yet their normal biological functions are not fully understood. As with other glycoconjugates and saccharides, solid phase display on microarrays potentially provides an effective platform for in vitro study of their functional interactions. However, with few exceptions, the most widely used microarray platforms display only the glycan moiety of GSLs, which not only ignores potential modulating effects of the lipid aglycone, but inherently limits the scope of application, excluding, for example, the major classes of plant and fungal GSLs. In this work, a prototype "universal" GSL-based covalent microarray has been designed, and preliminary evaluation of its potential utility in assaying protein-GSL binding interactions investigated. An essential step in development involved the enzymatic release of the fatty acyl moiety of the ceramide aglycone of selected mammalian GSLs with sphingolipid N-deacylase (SCDase). Derivatization of the free amino group of a typical lyso-GSL, lyso-G(M1), with a prototype linker assembled from succinimidyl-[(N-maleimidopropionamido)-diethyleneglycol] ester and 2-mercaptoethylamine, was also tested. Underivatized or linker-derivatized lyso-GSL were then immobilized on N-hydroxysuccinimide- or epoxide-activated glass microarray slides and probed with carbohydrate binding proteins of known or partially known specificities (i.e., cholera toxin B-chain; peanut agglutinin, a monoclonal antibody to sulfatide, Sulph 1; and a polyclonal antiserum reactive to asialo-G(M2)). Preliminary evaluation of the method indicated successful immobilization of the GSLs, and selective binding of test probes. The potential utility of this methodology for designing covalent microarrays that incorporate GSLs for serodiagnosis is discussed.
authors.affiliation: Department of Cellular and Molecular Medicine, University of Copenhagen, Denmark.
authors.forename: Emma
authors.initials: E
authors.lastname: Arigi
authors.forename: Ola
authors.initials: O
authors.lastname: Blixt
authors.forename: Karsten
authors.initials: K
authors.lastname: Buschard
authors.forename: Henrik
authors.initials: H
authors.lastname: Clausen
authors.forename: Steven B
authors.initials: SB
authors.lastname: Levery
mesh_terms: D000581:Amidohydrolases / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000032:analysis / Q000378:metabolism; D000918:Antibody Specificity; D002462:Cell Membrane / Q000737:chemistry; D002772:Cholera Toxin / Q000032:analysis / Q000378:metabolism; D054794:Glycomics / Q000379:methods*; D006028:Glycosphingolipids / Q000032:analysis* / Q000737:chemistry*; D046228:Microarray Analysis / Q000379:methods*; D015394:Molecular Structure; D019887:Peanut Agglutinin / Q000032:analysis / Q000378:metabolism; D011485:Protein Binding
chemical_list: D000911:Antibodies, Monoclonal; D006028:Glycosphingolipids; D019887:Peanut Agglutinin; D002772:Cholera Toxin; D000581:Amidohydrolases; C096410:sphingolipid ceramide N-deacylase
references.citation: Rapid Commun Mass Spectrom. 1999;13(18):1838-49
references.pmid: 10482898
references.citation: Diabetologia. 1994 Oct;37(10):1000-6
references.pmid: 7851678
references.citation: Nat Biotechnol. 2002 Oct;20(10):1011-7
references.pmid: 12219077
references.citation: Proteomics. 2002 Dec;2(12):1666-71
references.pmid: 12469336
references.citation: Tumour Biol. 2000 Jul-Aug;21(4):197-210
references.pmid: 10867613
references.citation: J Neurosci Res. 2001 Sep 1;65(5):363-70
references.pmid: 11536318
references.citation: J Neurol. 1991 Apr;238(2):75-9
references.pmid: 1856740
references.citation: Nat Biotechnol. 2002 Mar;20(3):275-81
references.pmid: 11875429
references.citation: J Lipid Res. 2000 May;41(5):846-51
references.pmid: 10787446
references.citation: Anal Chem. 2008 Mar 15;80(6):1835-46
references.pmid: 18278947
references.citation: Anal Biochem. 1996 Apr 5;236(1):35-40
references.pmid: 8619493
references.citation: APMIS. 1993 Dec;101(12):963-70
references.pmid: 8110453
references.citation: BMC Biotechnol. 2005 Jun 16;5:18
references.pmid: 15960850
references.citation: Methods Enzymol. 2000;311:297-303
references.pmid: 10563335
references.citation: J Biol Chem. 1989 Jul 25;264(21):12272-7
references.pmid: 2745442
references.citation: Glycobiology. 2006 Dec;16(12):21C-27C
references.pmid: 16971379
references.citation: Chem Biol. 2002 Apr;9(4):443-54
references.pmid: 11983333
references.citation: J Allergy Clin Immunol. 2009 Jun;123(6):1268-76.e15
references.pmid: 19443021
references.citation: Glycoconj J. 2008 Apr;25(3):269-78
references.pmid: 18197474
references.citation: Nat Med. 2006 Jan;12(1):138-43
references.pmid: 16341241
references.citation: J Biol Chem. 1986 Oct 25;261(30):14278-82
references.pmid: 3771534
references.citation: Methods Enzymol. 1982;83:235-41
references.pmid: 7098929
references.citation: J Mol Med (Berl). 1997 Aug;75(8):594-602
references.pmid: 9297627
references.citation: J Mass Spectrom. 2010 May;45(5):504-19
references.pmid: 20301184
references.citation: Biochemistry. 1973 Aug 28;12(18):3558-66
references.pmid: 4731192
references.citation: Chemistry. 2005 May 6;11(10):2894-901
references.pmid: 15635679
references.citation: Nat Methods. 2005 Nov;2(11):845-50
references.pmid: 16278655
references.citation: Biochem J. 1988 Apr 1;251(1):17-22
references.pmid: 2455508
references.citation: J Biol Chem. 1995 Oct 13;270(41):24370-4
references.pmid: 7592649
references.citation: Adv Exp Med Biol. 1980;125:339-48
references.pmid: 7361621
references.citation: Expert Rev Proteomics. 2010 Oct;7(5):761-74
references.pmid: 20973647
references.citation: Lancet. 1993 Oct 2;342(8875):840
references.pmid: 8104274
references.citation: Biochemistry. 1973 Aug 28;12(18):3547-58
references.pmid: 4731191
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17033-8
references.pmid: 15563589
references.citation: Nat Methods. 2011 Jan;8(1):85-90
references.pmid: 21131969
references.citation: Chem Soc Rev. 2008 Jul;37(7):1414-22
references.pmid: 18568167
references.citation: J Biol Chem. 1997 Feb 28;272(9):5533-8
references.pmid: 9038159
references.citation: Glycoconj J. 2002 Jul;19(6):403-13
references.pmid: 14707487
references.citation: Eur J Biochem. 2001 Feb;268(3):592-602
references.pmid: 11168398
references.citation: Anal Biochem. 1980 Dec;109(2):399-402
references.pmid: 7224165
references.citation: J Am Chem Soc. 2008 Sep 17;130(37):12348-54
references.pmid: 18712867
references.citation: Glycoconj J. 1998 Jan;15(1):51-62
references.pmid: 9530956
references.citation: Biol Chem. 2009 Jul;390(7):647-56
references.pmid: 19426131
references.citation: Autoimmunity. 2002 Nov;35(7):463-8
references.pmid: 12685874
references.citation: Org Biomol Chem. 2005 Jan 21;3(2):309-15
references.pmid: 15632974
references.citation: ACS Appl Mater Interfaces. 2009 Aug;1(8):1755-62
references.pmid: 20355792
references.citation: J Proteome Res. 2009 Sep;8(9):4301-10
references.pmid: 19624168
references.citation: Ann Clin Lab Sci. 2004 Winter;34(1):3-13
references.pmid: 15038664
references.citation: Biochemistry. 1996 May 21;35(20):6375-84
references.pmid: 8639583
references.citation: Nat Rev Mol Cell Biol. 2004 Jul;5(7):582-8
references.pmid: 15232576
references.citation: Tumour Biol. 1998;19 Suppl 1:1-20
references.pmid: 9422084
references.citation: Carbohydr Res. 2006 Jul 24;341(10):1209-34
references.pmid: 16716275
references.citation: Adv Lipid Res. 1993;26:253-74
references.pmid: 8379454
references.citation: Langmuir. 2010 Jun 1;26(11):8946-52
references.pmid: 20141177
references.citation: FEBS Lett. 1982 May 3;141(1):6-10
references.pmid: 6177556
references.citation: Infect Immun. 1973 May;7(5):759-63
references.pmid: 4202959
references.citation: Carbohydr Res. 2005 Sep 5;340(12):1963-72
references.pmid: 16005859
references.citation: Adv Exp Med Biol. 2001;491:369-402
references.pmid: 14533809